{
    "2018-03-23": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pharma Stock Roundup: ABBV's Rova-T Disappoints, J&J Unit Gets Buyout Offer",
                "features": {
                    "keywords": [
                        "ABBV",
                        "Rova-T",
                        "Disappoints",
                        "J&J",
                        "Buyout"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Will This Coming IPO Biotech Undercut Gilead, Novartis In Cancer Drugs?",
                "features": {
                    "keywords": [
                        "IPO",
                        "Biotech",
                        "Gilead",
                        "Novartis",
                        "Cancer"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Cancer Space Roundup: NVS' Tasigna & SGEN's Adcetris Label Expansions in Focus",
                "features": {
                    "keywords": [
                        "NVS",
                        "Tasigna",
                        "SGEN",
                        "Adcetris",
                        "Label Expansions"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Teva Is Implementing This Strategy as Part of Its Restructuring",
                "features": {
                    "keywords": [
                        "Teva",
                        "Restructuring",
                        "Strategy"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Key Updates on Teva’s Restructuring Plan Progress",
                "features": {
                    "keywords": [
                        "Teva",
                        "Restructuring",
                        "Plan",
                        "Progress"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "The Swiss Stock Market Dropped Further On Trade Concerns",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Dropped",
                        "Trade Concerns"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Incyte’s Revenue Stream in 4Q17",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Revenue",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Sandoz: CHMP Adopts Positive Opinion For Infliximab - Quick Facts",
                "features": {
                    "keywords": [
                        "Sandoz",
                        "CHMP",
                        "Positive Opinion",
                        "Infliximab"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Novartis' Tasigna Approved By FDA To Treat Children With Rare Form Of Leukemia",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Tasigna",
                        "FDA",
                        "Approval",
                        "Leukemia"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Novartis: Phase III Data Shows Siponimod Improves Outcomes In SPMS Patients",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Phase III",
                        "Siponimod",
                        "SPMS",
                        "Patients"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}